In two video interviews – recorded by the Myeloma Patients Europe – Dr. Annemieke Van Dongen-Leunis from the Erasmus School of Health Policy and Management, Erasmus University Rotterdam, explains the results of the research conducted within the MMpredict consortium. These findings were presented at the poster sessions during the 24th European Hematology Association (EHA) Congress which was held in Amsterdam, The Netherlands, from 13 to 16 June 2019. Within the first video the data of a European multinational quality of life study under multiple myeloma patients was discussed.

The second movie presented the analysis of the cost-effectiveness of risk stratified treatment in transplant eligible patients.

© MMH2020